Friday, September 1, 2017

Quercetin plus dasatinib shows promise for bone maintenance

Senolytic drugs are targeting basic aging processes and could have widespread application in treating multiple chronic diseases.

http://www.prohealth.com/track_pro.cfm?id=7151&libid=30717